Cholesterol Rich Liposomes
Cholesterol Rich Liposomes - Related Videos
10:33
Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
0 Views •
Cited by 18 •
2016
The goal of this protocol is to use cationic/anionic liposomes with a neuro-targeting peptide as a CNS delivery system to enable siRNA to cross the BBB. The optimization of a delivery system for treatments, like siRNA, would allow for more treatment options for prion and other neurodegenerative diseases.
11:07
Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans
0 Views •
Cited by 22 •
2014
In this article, a protocol for infection of macrophages with Cryptococcus neoformans is described. Also, a method for sterol depletion from the macrophages is explained. These protocols provide a guide to study fungal infections in vitro and examine the role of sterols in such infections.
09:03
Giant Liposome Preparation for Imaging and Patch-Clamp Electrophysiology
0 Views •
Cited by 23 •
2013
Reconstituting functional membrane proteins into giant liposomes of defined composition is a powerful approach when combined with patch-clamp electrophysiology. However, conventional giant liposome production may be incompatible with protein stability. We describe protocols for producing giant liposomes from pure lipids or small liposomes containing ion channels.
01:29
Cholesterol: Significance and Regulation
0 Views •
2024
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces. Considering cholesterol and...
07:54
Cholesterol Efflux Assay
0 Views •
Cited by 74 •
2012
The cholesterol assay is designed to quantitate the rate of cholesterol efflux from cultured cells and the capacity of plasma acceptors to accept cholesterol released from cells. The assay consists of labelling cells with cholesterol, equilibration of cholesterol among intracellular pools and release of cholesterol to an extracellular acceptor.
FAQs
Cholesterol inserts between phospholipids and changes how closely the lipid molecules pack. This adjustment affects membrane fluidity, permeability, and resistance to disruption, allowing researchers to tune the vesicle’s physical behavior rather than treating the bilayer as a fixed structure. These properties are important when designing liposomes that must retain cargo or interact with biological environments.
Changing cholesterol content modifies the organization and performance of the bilayer, which can influence how readily substances cross the membrane and how well the vesicle resists disruption. Because liposomes may carry soluble compounds in their aqueous core or membrane-associated compounds in the bilayer, cholesterol provides one variable for balancing structural stability with cargo retention.
Their behavior depends not only on the presence of cholesterol but also on its proportion relative to the phospholipids and on the overall lipid composition. Altering these variables can change packing, fluidity, permeability, and resistance to disruption. Consequently, two vesicle systems can provide different delivery or membrane-model performance even when they carry similar types of compounds.
Researchers adjust cholesterol content together with lipid composition and preparation conditions. Considering these factors as a coordinated design set helps connect formulation choices with vesicle stability, cargo retention, and interactions with biological environments. This approach is useful in bioengineering because it supports deliberate tuning of membrane performance for a specific delivery or biomimetic purpose.
A supported design workflow begins by selecting the intended cargo and deciding whether it should occupy the aqueous core or associate with the membrane. Researchers then choose the lipid composition, set the cholesterol proportion, and establish preparation conditions. The resulting vesicles can be evaluated for stability, cargo retention, and interactions with the relevant biological environment.
They are useful when a delivery system must accommodate either soluble compounds within an aqueous compartment or membrane-associated compounds within the lipid bilayer. Cholesterol and the surrounding lipid composition can then be adjusted to influence retention and resistance to disruption. These design features support engineered delivery systems whose membrane behavior is matched to the intended cargo.
These vesicles can serve as drug-delivery systems, biomimetic membranes, and platforms for studying membrane interactions. Measurements or observations focused on stability, cargo retention, permeability, fluidity, and resistance to disruption help researchers relate lipid design to function. In this way, the system provides both an engineered carrier and a controllable model of membrane behavior.